SCHEMBL17078207

SCHEMBL17078207

C/C=C/C=C/C=C/C(=O)Oc1cc(/C=C/c2ccc(O)cc2)cc(OC(=O)/C=C/C=C/C=C/C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.53
▸ MAPT P10636 5/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ TTR P02766 4/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ PTGS2 P35354 4/20 0.53
▸ CYP1A1 P04798 3/20 0.53
▸ ALOX5 P09917 3/20 0.53
▸ CYP1B1 Q16678 3/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ ABL1 P00519 2/20 0.53
▸ ABCB1 P08183 2/20 0.53
▸ GAA P10253 2/20 0.53
▸ BCR P11274 2/20 0.53
▸ NQO2 P16083 2/20 0.53
▸ PTGS1 P23219 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ GFER P55789 2/20 0.53
▸ HDAC6 Q9UBN7 2/20 0.53
▸ MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20394921 1.00 MEN1 (0.53) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL2520244 0.99 MEN1 (0.54) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL18383810 0.96 PTGS2 (0.54) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL20406906 0.95 TTR (0.62) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL2515241 0.94 PTGS2 (0.55) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL17078203 0.92 KMT2A (0.60) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL20394912 0.92 KMT2A (0.60) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL2516279 0.90 KMT2A (0.62) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL2516228 0.89 KMT2A (0.58) MEN1MAPTKMT2ATTRKDM4E
SCHEMBL18383806 0.87 KMT2A (0.56) MEN1MAPTKMT2ATTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP claimed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US claimed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US claimed
EP-3116849-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR Giuliani S.p.A. (IT) 2017-01-18 — — EP claimed
WO-2015135927-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2015-09-17 — — WO claimed
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP disclosed
EP-3116849-B1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI SPA (IT) 2018-07-25 — — EP disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-9738682-B2 Compounds with a combined antioxidant activity against free radicals together with an anti-inflammatory action, and pharmaceutical and cosmetic compositions containing them for the treatment of skin and hair GIULIANI S.P.A. (IT) 2017-08-22 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2017-01-19 — — US disclosed
EP-3116849-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR Giuliani S.p.A. (IT) 2017-01-18 — — EP disclosed
WO-2015135927-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR GIULIANI S.P.A. (IT) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170015700-A1 COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR ARG1, ARG2, TYR MEN1 4365/4885MAPT 4337/4885KMT2A 3121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback